Umbrella Study of Sasanlimab Combined with Targeted Therapies for NSCLC
On November 30th, 2021
No comments have been posted yet.
The General Data Protection Regulation (GDPR) became effective on May 25, 2018, and may affect the collection of personal data from non-U.S. users. At MOASC, data privacy and security have always been a top priority, and we have been working hard to ensure compliance with GDPR. If you have any questions regarding the use or safeguarding of your data, then please review our updated Privacy Policy. Our updated Privacy Policy also contains important information on the use of Cookies, Web Beacons or Pixels. By using our services after the effective date of the new policy, you will be accepting the new Privacy Policy terms and Our Terms of Use. Any questions or concerns, please feel free to email us at moasc@moasc.org.OkPrivacy policy
No comments have been posted yet.